Management of oral secretions in neurological disease

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Practical Neurology

• Publication date

  2017-02-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/practneurol-2016-001515PMID 28188210
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The physiology of salivary secretion.

  2016cited by this paper
• Four-Duct Ligation for the Treatment of Sialorrhea in Children.

  2016cited by this paper
• The role of radiation therapy in the management of sialorrhea: A systematic review

  2016cited by this paper
• Very Low Dose Amitriptyline for Clozapine-Associated Sialorrhea.

  2016cited by this paper
• Management of drooling in children with cerebral palsy: A French survey.

  2016cited by this paper
• Long-term follow-up of ultrasound-guided botulinum toxin-A injections for sialorrhea in neurological dysphagia

  2015cited by this paper
• Clinical differences between botulinum neurotoxin type A and B.

  2015cited by this paper
• Sublingual administration of atropine eyedrops in children with excessive drooling – a pilot study

  2015cited by this paper
• Drooling quantification: Correlation of different techniques.

  2015cited by this paper
• Pre- and Post-synaptic Effects of Botulinum Toxin A on Submandibular Glands

  2015cited by this paper
• Salivary botulinum toxin injection may reduce aspiration pneumonia in neurologically impaired children.

  2015cited by this paper
• Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview.

  2015cited by this paper
• A Review of Options for Treating Sialorrhea in Amyotrophic Lateral Sclerosis

  2015cited by this paper
• Repeated treatments of drooling with botulinum toxin B in neurology

  2015cited by this paper
• An unusual complication of Botox treatment for sialorrhoea

  2014cited by this paper
• Drooling in Parkinson's disease: a review.

  2014cited by this paper
• Validation of robust tools to measure sialorrhea in amyotrophic lateral sclerosis: A study in a large French cohort

  2013cited by this paper
• Botulinum Toxin for the Treatment of Sialorrhea

  2013cited by this paper
• Absence of Airway Secretion Accumulation Predicts Tolerance of Noninvasive Ventilation in Subjects With Amyotrophic Lateral Sclerosis

  2013cited by this paper
• Anticholinergics in Palliative Medicine

  2013cited by this paper
• Dysphagia and sialorrhea: the relationship to Parkinson's disease.

  2013cited by this paper
• Management of sialorrhoea in motor neuron disease: A survey of current UK practice

  2013cited by this paper
• Botulinum toxin use in neuro-rehabilitation to treat obstetrical plexus palsy and sialorrhea following neurological diseases: A review

  2012cited by this paper
• EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force

  2012cited by this paper
• Glycopyrrolate Oral Solution

  2012cited by this paper
• Safety and efficacy of glycopyrrolate oral solution for management of pathologic drooling in pediatric patients with cerebral palsy and other neurologic conditions

  2012cited by this paper
• Glycopyrrolate for chronic drooling in children.

  2012cited by this paper
• The management of drooling in adults with neurological conditions.

  2012cited by this paper
• The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease

  2011cited by this paper
• Silent saliva aspiration in Parkinson's disease

  2011cited by this paper
• Thickened saliva after effective management of drooling with botulinum toxin A

  2010cited by this paper
• Oromotor dysfunction and communication impairments in children with cerebral palsy: a register study

  2010cited by this paper
• Management of drooling in disabled patients with scopolamine patches.

  2010cited by this paper
• Glycopyrrolate for sialorrhea in Parkinson disease

  2010cited by this paper
• Surgical management of drooling: a meta-analysis.

  2009cited by this paper
• Systematic review of the effectiveness of botulinum toxin or radiotherapy for sialorrhea in patients with amyotrophic lateral sclerosis.

  2009cited by this paper
• Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review)

  2009cited by this paper
• Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson's disease

  2007cited by this paper
• Prevalence of drooling in children with cerebral palsy attending special schools

  2007cited by this paper
• Immunological aspects of Botox®, Dysport® and MyoblocTM/NeuroBloc®

  2006cited by this paper
• Botulinum toxin type B de novo therapy of cervical dystonia: frequency of antibody induced therapy failure.

  2005cited by this paper
• Sialorrhea: a management challenge.

  2004cited by this paper
• Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs

  2003cited by this paper
• Prevalence of drooling in children with cerebral palsy attending special schools.

  2003cited by this paper
• Evaluation of the Therapeutic Usefulness of Botulinum Neurotoxin B, C1, E, and F Compared with the Long Lasting Type A

  2003cited by this paper
• Sublingual Atropine for sialorrhea secondary to parkinsonism: A pilot study

  2002cited by this paper
• Respiratory complications related to bulbar dysfunction in motor neuron disease

  2001cited by this paper
• Drooling in Parkinson's disease: a novel speech and language therapy intervention.

  2001cited by this paper
• Anticholinergic side-effects of drugs in elderly people

  2000cited by this paper
• The control of oral secretions in bulbar ALS/MND.

  1996cited by this paper
• The prediction of saliva swallowing frequency in humans from estimates of salivary flow rate and the volume of saliva swallowed.

  1995cited by this paper
• An intraoral prosthesis to control drooling in a patient with amyotrophic lateral sclerosis.

  1991cited by this paper
• Salivary gland dysfunction and swallowing disorders.

  1988cited by this paper
• On the Physiology of the Salivary Secretion

  1878cited by this paper

• Targeted transdermal scopolamine delivery over the salivary glands for sialorrhea: Dose-response and systemic safety in rats.

  2026cites this paper
• The use of Botulinum Toxin Type A in patients in out-of-hospital intensive care in Germany—results from a multidisciplinary online survey

  2025cites this paper
• Exploration of Nurses’ Preventive Practices for Aspiration Pneumonia Among Poststroke Patients at a Teaching Hospital in Ghana: A Qualitative Study

  2025cites this paper
• Co-Design and Non-Randomised Pilot Evaluation of Resources Developed to Optimise Saliva Management in People with Motor Neurone Disease

  2025cites this paper
• Consensus statement on the need for a specialist service for paediatric saliva control in neurodevelopmental disabilities

  2025cites this paper
• Effectiveness of repetitive transcranial magnetic stimulation on hypomimia induced sialorrhea among Parkinsons: a case study

  2025cites this paper
• The impact of drooling on the lives of people with Parkinson’s disease

  2025cites this paper
• The Role of Pharmacological Drying Agents in Weaning the Neurological Tracheostomised Patient

  2025cites this paper
• Use of botulinum toxin in patients with dysphagia and sialorrhea in acute ischemic stroke

  2025cites this paper
• The Validation of the Italian Version of the Munich Swallowing Score (IT-MUCSS) Against the Fiberoptic Endoscopic Evaluation of Swallowing and Food Intake Modalities in Patients with Neurogenic Dysphagia: A Cross-Sectional Study

  2025cites this paper
• Further development of a patient-reported outcome measure to assess the impact of oral secretion problems in people living with MND

  2025cites this paper
• The Role of Speech Therapy in Sialorrhea Management and Quality of Life: A Retrospective Study

  2025cites this paper
• The effectiveness and safety of botulinum toxin treatment for sialorrhea due to severe brain injury

  2025cites this paper
• Saliva as a Diagnostic Tool for Systemic Diseases—A Narrative Review

  2025cites this paper
• Perioperative Management in Neuromuscular Diseases: A Narrative Review

  2024cites this paper
• Understanding Clinical Effectiveness and Safety Implications of Botulinum Toxin in Children: A Narrative Review of the Literature

  2024cites this paper
• Intraoral Acupuncture for Sialorrhea in Stroke Patients: a Study Protocol for a Randomized Controlled Trial

  2024cites this paper
• Advances in symptom management and in monitoring disease progression in motor neuron disease.

  2024cites this paper
• Parkinson's disease - The dentist's role as part of the healthcare team.

  2024cites this paper
• Ictal hypersalivation as a prominent symptom in a girl with insulo‐opercular epilepsy

  2023cites this paper
• Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children—update and practice recommendations

  2023cites this paper
• Application Site of Transdermal Scopolamine Influences Efficacy and Drug Concentration in Salivary Glands in Rats.

  2023cites this paper
• Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson’s disease

  2023influential citation
• The effectiveness and safety of botulinum toxin injections for the treatment of sialorrhea with Parkinson's disease: a systematic review and meta-analysis

  2023cites this paper
• The complexity of multidisciplinary respiratory care in amyotrophic lateral sclerosis

  2023cites this paper
• Comparison of factors associated with drooling between intractable neuromuscular disease and cerebral palsy.

  2023cites this paper
• Effectiveness of the pharmacological treatments for sialorrhea in patients with Parkinson’s disease: a systematic review and network meta-analysis

  2023cites this paper
• Sialorrhea with Neurological Diseases in Oral Medicine Fields: A Narrative Review

  2022cites this paper
• A Case Report of Systemic Intoxication Following Onabotulinum Toxin A Injections Into the Salivary Glands in a Patient With Spinal Muscular Atrophy Type 1.

  2022cites this paper
• Gastrointestinal Dysfunction in Parkinson’s Disease

  2022cites this paper
• Botulinum Toxin A in the Management of Pediatric Sialorrhea: A Systematic Review

  2022cites this paper
• Occurrence of acute cholinergic syndrome in an infant due to donepezil ingestion

  2022cites this paper
• Drooling in Parkinson's disease and current treatment options

  2022cites this paper
• Therapie der Sialorrhoe mit Botulinumtoxin – ein Update

  2022cites this paper
• Proposing a Multisystem Swallowing Framework: A Network Medicine Approach in the Era of COVID-19

  2022cites this paper
• Sialorrhea in patients with Parkinson's disease: A case report

  2022cites this paper
• Impact and management of drooling in children with neurological disorders: an Italian Delphi consensus

  2022cites this paper
• Pulmonological issues.

  2022cites this paper
• Diagnosis and treatment of pneumonia, a common cause of respiratory failure in patients with neuromuscular disorders

  2021cites this paper
• Botulinum in selected neurological disorders - review

  2021cites this paper
• US-guided percutaneous microwave ablation (MWA) of submandibular gland: A new minimal invasive and effective treatment for refractory sialorrhea and treatment response evaluation with contrast-enhanced imaging techniques

  2021cites this paper
• Management and Treatment of Drooling: Focus on Non-Invasive Therapy for Children

  2021cites this paper
• Submandibular Gland Excision in Pediatric Patients

  2021cites this paper
• Sialorrhoea Management Practices in Residential Older Adults Care Settings: A Qualitative Study.

  2020cites this paper
• Exploring treatments for drooling in children with neurological disorders

  2020cites this paper
• Sialorrhea in Parkinson’s Disease

  2020influential citation
• Salivary changes, oral symptoms, and oral health-related quality of life in patients with neuromuscular diseases

  2020cites this paper
• Efficacy of scopolamine transdermal patch in children with sialorrhea in a pediatric tertiary care hospital

  2020cites this paper
• A Tutorial on Saliva's Role in Swallowing With a Focus on Sjögren's Syndrome.

  2020cites this paper
• The Challenges Faced and Lessons Learnt in the Multidisciplinary Management of Medication Refractory Post-Stroke Sialorrhea: A Case Report

  2020cites this paper
• Neurologic and Neurodegenerative Diseases of the Larynx

  2020cites this paper
• Localization of Salivary Glands for Botulinum Toxin Treatment: Ultrasound Versus Landmark Guidance

  2020cites this paper
• Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults

  2020cites this paper
• Saliva Management

  2020cites this paper
• SIAXI

  2019cites this paper
• Respiratory Failure in Amyotrophic Lateral Sclerosis

  2019cites this paper
• Effects of chronic treatment with botulinum toxin type A in salivary glands of rats: Histological and immunohistochemical analyses.

  2019cites this paper
• The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®)

  2019cites this paper
• Long-term incobotulinumtoxinA treatment for chronic sialorrhea: Efficacy and safety over 64 weeks.

  2019cites this paper
• Therapy of Sialorrhea with Botulinum Neurotoxin

  2019cites this paper
• Acute Dyspnoea

  2019cites this paper
• [Therapy of sialorrhea with botulinum toxin].

  2019cites this paper
• A systematic review of non-invasive and invasive sialorrhoea management.

  2019cites this paper
• IncobotulinumtoxinA for hypersalivation in patients with amyotrophic lateral sclerosis: an open-label single-centre study

  2019cites this paper
• Otolaryngologic Symptoms in Multiple Sclerosis: A Review

  2018cites this paper
• Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated

  2018cites this paper
• Onabotulinum Toxin A Injections Into the Salivary Glands for Spinal Muscle Atrophy Type I: A Prospective Case Series of 4 Patients

  2018cites this paper
• Use of Non-invasive Ventilation in Neuromuscular Disease

  2017cites this paper
• Efficacy of Incobotulinumtoxin Type A (Xeomin ® ) in the Management of Sialorrhea in Neurodegenerative Diseases

  2017cites this paper
• Botulinum toxin: State of the art

  2017cites this paper
• Tracheostomy and salivary gland radiotherapy for severe sialorrhoea in motor neurone disease

  2017cites this paper
• Swallowing in Parkinson's disease: clinical issues and management.

  2017cites this paper
• Botulinum neurotoxin for sialorrhea: a first choice therapy

  2017cites this paper